Abstract |
Nanoparticle mediated delivery of antineoplastic agents, functionalized with monoclonal antibodies has achieved extraordinary potential in cancer therapy. The objective of this study was to develop a drug delivery system comprising O-carboxymethyl chitosan (O-CMC) nanoparticles, surface-conjugated with Cetuximab (Cet) for targeted delivery of paclitaxel (PTXL) to Epidermal Growth Factor Receptor (EGFR) over-expressing cancer cells. Nanoparticles around 180±35nm and negatively charged were prepared through simple ionic gelation technique. The alamar blue assay indicated that these targeted nanoparticles displayed a superior anticancer activity compared to non-targeted nanoparticles. The nanoformulation triggered enhanced cell death (confirmed by flow cytometry) due to its higher cellular uptake. The selective uptake of Cet-PTXL-O-CMC nanoparticles by EGFR +VE cancer cells (A549, A431 and SKBR3) compared to EGFR -VE MIAPaCa-2 cells confirms the active targeting and delivery of PTXL via the targeted nanomedicine. Cet-PTXL-O-CMC nanoparticles can be used a promising candidate for the targeted therapy of EGFR over expressing cancers.
|
Authors | S Maya, Lekshmi G Kumar, Bruno Sarmento, N Sanoj Rejinold, Deepthy Menon, Shantikumar V Nair, R Jayakumar |
Journal | Carbohydrate polymers
(Carbohydr Polym)
Vol. 93
Issue 2
Pg. 661-9
(Apr 02 2013)
ISSN: 1879-1344 [Electronic] England |
PMID | 23499109
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 Elsevier Ltd. All rights reserved. |
Chemical References |
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
- Biomarkers, Tumor
- O-carboxymethylchitosan
- Oxazines
- Xanthenes
- resazurin
- Chitosan
- ErbB Receptors
- Cetuximab
|
Topics |
- Antibodies, Monoclonal, Humanized
(administration & dosage, chemistry, pharmacology)
- Antineoplastic Agents
(administration & dosage)
- Biomarkers, Tumor
(metabolism)
- Cell Death
- Cell Line, Tumor
- Cetuximab
- Chemistry, Pharmaceutical
(methods)
- Chitosan
(administration & dosage, analogs & derivatives)
- Drug Delivery Systems
(methods)
- Drug Screening Assays, Antitumor
- ErbB Receptors
(metabolism)
- Erythrocytes
(drug effects, ultrastructure)
- Hemolysis
(drug effects)
- Humans
- Microscopy, Electron, Scanning
- Nanoparticles
(administration & dosage, chemistry)
- Nanotechnology
(methods)
- Oxazines
(chemistry)
- Particle Size
- Xanthenes
(chemistry)
|